These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2892410)

  • 21. Use and abuse of H2 receptor antagonists.
    Hunt RH
    J R Coll Physicians Lond; 1982 Jan; 16(1):33-9. PubMed ID: 6121053
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of cimetidine and ranitidine on cardiovascular drugs.
    Baciewicz AM; Baciewicz FA
    Am Heart J; 1989 Jul; 118(1):144-54. PubMed ID: 2662728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of H2-blocking agents on hepatocytes in vitro: correlation with potential for causing hepatic disease in patients.
    Zimmerman HJ; Jacob L; Bassan H; Gillespie J; Lukacs L; Abernathy CO
    Proc Soc Exp Biol Med; 1986 Sep; 182(4):511-4. PubMed ID: 2874563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative in vitro and in vivo inhibition of cytochrome P450 CYP1A2, CYP2D6, and CYP3A by H2-receptor antagonists.
    Martínez C; Albet C; Agúndez JA; Herrero E; Carrillo JA; Márquez M; Benítez J; Ortiz JA
    Clin Pharmacol Ther; 1999 Apr; 65(4):369-76. PubMed ID: 10223772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative effects of H2-receptor antagonists on drug interaction in rats.
    Lin JH; Cocchetto DM; Yeh KC; Duggan DE
    Drug Metab Dispos; 1986; 14(6):649-53. PubMed ID: 2877821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Zaltidine: an effective but hepatotoxic H2-receptor antagonist.
    Farup PG
    Scand J Gastroenterol; 1988 Aug; 23(6):655-8. PubMed ID: 2902681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [H2 antagonists as inhibitors of cytochrome P-450 in rat liver: in vitro and in vivo effects].
    Carrasco M; Gaule C; Vega P; del Villar E
    Rev Med Chil; 1992 May; 120(5):539-44. PubMed ID: 1364175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IgE-mediated drug fever due to histamine H2-receptor blockers.
    Hiraide A; Yoshioka T; Ohshima S
    Drug Saf; 1990; 5(6):455-7. PubMed ID: 1981005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Review of histamine H2 receptor antagonists].
    García Plaza A; Pascasio Acevedo JM
    Rev Esp Enferm Apar Dig; 1984 Oct; 66(4):288-94. PubMed ID: 6151218
    [No Abstract]   [Full Text] [Related]  

  • 30. [Possibly ranitidine-induced autoimmune hepatitis].
    Luparini RL; Rotundo A; Mattace R; Marigliano V
    Ann Ital Med Int; 2000; 15(3):214-7. PubMed ID: 11059062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection by cimetidine, but not ranitidine, implies that H2 receptors do not mediate arrhythmogenesis in a rat model of regional ischaemia and reperfusion in vitro.
    Banning MM; Curtis MJ
    Cardiovasc Res; 1995 Nov; 30(5):705-10. PubMed ID: 8595616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential use of cimetidine for treatment of acetaminophen overdose.
    Speeg KV
    Pharmacotherapy; 1987; 7(6 Pt 2):125S-133S. PubMed ID: 3328168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [H2 antagonists and the heart].
    Corradini P; Zocchi M; Buonavia A
    Minerva Med; 1986 Dec; 77(47-48):2209-15. PubMed ID: 2880317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New histamine H2-receptor antagonists.
    Domschke S; Domschke W
    Hepatogastroenterology; 1980 Jun; 27(3):163-8. PubMed ID: 6109690
    [No Abstract]   [Full Text] [Related]  

  • 35. Histamine H2-receptor antagonists have no clinically significant effect on the steady-state pharmacokinetics of voriconazole.
    Purkins L; Wood N; Kleinermans D; Nichols D
    Br J Clin Pharmacol; 2003 Dec; 56 Suppl 1(Suppl 1):51-5. PubMed ID: 14616414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.
    Cavanagh RL; Usakewicz JJ; Buyniski JP
    J Pharmacol Exp Ther; 1983 Jan; 224(1):171-9. PubMed ID: 6129316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The interaction between H2-receptor antagonists and beta-adrenoceptor blockers.
    Mutschler E; Spahn H; Kirch W
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):51S-57S. PubMed ID: 6146340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug interactions affecting analgesic toxicity.
    Prescott LF; Critchley JA
    Am J Med; 1983 Nov; 75(5A):113-6. PubMed ID: 6359860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histamine H2-receptor antagonists in the short- and long-term treatment of duodenal ulcer.
    Thomas JM; Misiewicz G
    Clin Gastroenterol; 1984 May; 13(2):501-41. PubMed ID: 6146417
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of H2-receptor antagonists on steady-state extraction of indocyanine green and lidocaine by the perfused rat liver.
    Roberts RK; Heath CA; Johnson RF; Speeg KV; Schenker S
    J Lab Clin Med; 1986 Feb; 107(2):112-7. PubMed ID: 2868064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.